Jean‐Marc Hoffmann

538 total citations
20 papers, 311 citations indexed

About

Jean‐Marc Hoffmann is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Jean‐Marc Hoffmann has authored 20 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Jean‐Marc Hoffmann's work include CAR-T cell therapy research (9 papers), Virus-based gene therapy research (3 papers) and RNA Interference and Gene Delivery (3 papers). Jean‐Marc Hoffmann is often cited by papers focused on CAR-T cell therapy research (9 papers), Virus-based gene therapy research (3 papers) and RNA Interference and Gene Delivery (3 papers). Jean‐Marc Hoffmann collaborates with scholars based in Germany, Switzerland and United Kingdom. Jean‐Marc Hoffmann's co-authors include Michael Schmitt, Maria‐Luisa Schubert, Anita Schmitt, Carsten Müller‐Tidow, Peter Dreger, Leopold Sellner, Ulrike Gern, Lei Wang, Sophia Stock and Susanne Hofmann and has published in prestigious journals such as The Lancet, Blood and Scientific Reports.

In The Last Decade

Jean‐Marc Hoffmann

19 papers receiving 306 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean‐Marc Hoffmann Germany 9 248 103 91 86 63 20 311
Diane Baniewicz United States 12 388 1.6× 87 0.8× 91 1.0× 97 1.1× 84 1.3× 16 495
George Hucks United States 7 302 1.2× 84 0.8× 82 0.9× 97 1.1× 81 1.3× 11 359
Vipul Sheth United States 7 184 0.7× 84 0.8× 58 0.6× 50 0.6× 44 0.7× 22 273
Minh Tran United States 6 141 0.6× 69 0.7× 80 0.9× 36 0.4× 48 0.8× 13 259
Monalisa Ghosh United States 9 170 0.7× 63 0.6× 87 1.0× 26 0.3× 56 0.9× 45 308
Sandra B. Horowitz United States 9 227 0.9× 65 0.6× 77 0.8× 40 0.5× 49 0.8× 14 305
Bryan Do United States 6 187 0.8× 53 0.5× 49 0.5× 37 0.4× 45 0.7× 7 288
Mimi Leung United States 6 144 0.6× 83 0.8× 72 0.8× 26 0.3× 33 0.5× 10 235
Yuehui Lin China 8 250 1.0× 57 0.6× 53 0.6× 61 0.7× 59 0.9× 27 292
David M. Cordas dos Santos Germany 8 251 1.0× 45 0.4× 82 0.9× 34 0.4× 32 0.5× 16 304

Countries citing papers authored by Jean‐Marc Hoffmann

Since Specialization
Citations

This map shows the geographic impact of Jean‐Marc Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Marc Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Marc Hoffmann more than expected).

Fields of papers citing papers by Jean‐Marc Hoffmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Marc Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Marc Hoffmann. The network helps show where Jean‐Marc Hoffmann may publish in the future.

Co-authorship network of co-authors of Jean‐Marc Hoffmann

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Marc Hoffmann. A scholar is included among the top collaborators of Jean‐Marc Hoffmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Marc Hoffmann. Jean‐Marc Hoffmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thabane, Lehana, Sally Hopewell, An‐Wen Chan, et al.. (2025). Reporting of environmental outcomes in randomised clinical trials: a protocol for a scoping review. BMJ Open. 15(9). e101709–e101709.
2.
Hoffmann, Jean‐Marc, et al.. (2024). Academic vs. industry-sponsored trials: A global survey on differences, similarities, and future improvements. Journal of Global Health. 14. 4204–4204. 1 indexed citations
3.
Ludwig, Roman, Adrian D. Schubert, Jean‐Marc Hoffmann, et al.. (2024). Modelling the lymphatic metastatic progression pathways of OPSCC from multi-institutional datasets. Scientific Reports. 14(1). 15750–15750. 5 indexed citations
4.
Thabane, Lehana, Sally Hopewell, An‐Wen Chan, et al.. (2024). Integrating environmental outcomes in randomised clinical trials: a call to action. The Lancet. 405(10477). 446–448. 4 indexed citations
5.
Hoffmann, Jean‐Marc, et al.. (2023). The carbon footprint of clinical trials: a global survey on the status quo and current regulatory guidance. BMJ Global Health. 8(9). e012754–e012754. 8 indexed citations
6.
Hoffmann, Jean‐Marc, et al.. (2023). Toward a global harmonization of service infrastructure in academic clinical trial units: an international survey. Frontiers in Medicine. 10. 1252352–1252352. 3 indexed citations
7.
Hoffmann, Jean‐Marc, et al.. (2022). Academic clinical trials: Publication of study results on an international registry—We can do better!. Frontiers in Medicine. 9. 1069933–1069933. 4 indexed citations
8.
Ludwig, Roman, Jean‐Marc Hoffmann, Bertrand Pouymayou, et al.. (2022). A dataset on patient-individual lymph node involvement in oropharyngeal squamous cell carcinoma. Data in Brief. 43. 108345–108345. 7 indexed citations
9.
Ludwig, Roman, Jean‐Marc Hoffmann, Bertrand Pouymayou, et al.. (2022). Detailed patient-individual reporting of lymph node involvement in oropharyngeal squamous cell carcinoma with an online interface. Radiotherapy and Oncology. 169. 1–7. 9 indexed citations
10.
Yoo, Keun-Young, Yibin Liu, Lei Wang, et al.. (2019). Tumor-Specific Reactive Oxygen Species Accelerators Improve Chimeric Antigen Receptor T Cell Therapy in B Cell Malignancies. International Journal of Molecular Sciences. 20(10). 2469–2469. 15 indexed citations
11.
Gong, Wenjie, Jean‐Marc Hoffmann, Sophia Stock, et al.. (2019). Comparison of IL-2 vs IL-7/IL-15 for the generation of NY-ESO-1-specific T cells. Cancer Immunology Immunotherapy. 68(7). 1195–1209. 41 indexed citations
12.
Stock, Sophia, Jean‐Marc Hoffmann, Maria‐Luisa Schubert, et al.. (2018). Influence of Retronectin-Mediated T-Cell Activation on Expansion and Phenotype of CD19-Specific Chimeric Antigen Receptor T Cells. Human Gene Therapy. 29(10). 1167–1182. 21 indexed citations
13.
Hoffmann, Jean‐Marc, Maria‐Luisa Schubert, Lei Wang, et al.. (2018). Differences in Expansion Potential of Naive Chimeric Antigen Receptor T Cells from Healthy Donors and Untreated Chronic Lymphocytic Leukemia Patients. Frontiers in Immunology. 8. 1956–1956. 83 indexed citations
14.
Ni, Ming, Lei Wang, Angela Hückelhoven, et al.. (2018). No Inhibition of Anti-Viral and Anti-Leukemia Effects By Extracorporeal Photopheresis Therapy. Blood. 132(Supplement 1). 3399–3399. 1 indexed citations
15.
Hoffmann, Jean‐Marc, Michael Schmitt, Ming Ni, & Anita Schmitt. (2017). Next-Generation Dendritic Cell-Based Vaccines for Leukemia Patients. Immunotherapy. 9(2). 173–181. 7 indexed citations
16.
Schubert, Maria‐Luisa, Jean‐Marc Hoffmann, Peter Dreger, Carsten Müller‐Tidow, & Michael Schmitt. (2017). Chimeric antigen receptor transduced T cells: Tuning up for the next generation. International Journal of Cancer. 142(9). 1738–1747. 40 indexed citations
17.
Ni, Ming, Jean‐Marc Hoffmann, Michael Schmitt, & Anita Schmitt. (2016). Progress of dendritic cell-based cancer vaccines for patients with hematological malignancies. Expert Opinion on Biological Therapy. 16(9). 1113–1123. 7 indexed citations
18.
Schubert, Maria‐Luisa, Angela Hückelhoven, Jean‐Marc Hoffmann, et al.. (2016). Chimeric Antigen Receptor T Cell Therapy Targeting CD19-Positive Leukemia and Lymphoma in the Context of Stem Cell Transplantation. Human Gene Therapy. 27(10). 758–771. 32 indexed citations
20.
Hoffmann, Jean‐Marc, et al.. (1993). Tumoristatic Activity of Liposomes Reconstituted from Tumor Associated Antigens and Interleukin 2 for Immunotherapy of Fibrosarcomas in BALB/C MICE. Journal of Liposome Research. 3(1). 107–121. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026